+ helper T cells that are critical for preventing autoimmunity and ideal for cell-based immunotherapy of autoimmunity and prevention of transplant rejection 1 . T reg cells express the master transcription factor FOXP3, the interleukin-2 (IL-2) receptor component CD25 and the inhibitory co-receptor CTLA4 2 , and depend on the transcription factor BACH2 3 . T reg cells are derived thymically and peripherally and can also be induced in vitro. There are no universally accepted ways to distinguish these populations, although expression of Helios and neuropilin and methylation status of the T reg cell-specific demethylation region (TSDR) have been proposed [4] [5] [6] [7] [8] . These transcription factors are considered to antagonize T reg cell development: in mice, induction of high T-bet expression in T reg cells within inflamed bowel drives T reg cells into a pro-inflammatory phenotype reminiscent of T H 1 cells 10 . This view has been challenged by specific deletions of these factors specifically within Foxp3 + cells of mice [11] [12] [13] [14] . For example, T-bet expression within Foxp3
R egulatory T (T reg ) cells are a non-redundant, suppressive subset of CD4
+ helper T cells that are critical for preventing autoimmunity and ideal for cell-based immunotherapy of autoimmunity and prevention of transplant rejection 1 . T reg cells express the master transcription factor FOXP3, the interleukin-2 (IL-2) receptor component CD25 and the inhibitory co-receptor CTLA4 2 , and depend on the transcription factor BACH2 3 . T reg cells are derived thymically and peripherally and can also be induced in vitro. There are no universally accepted ways to distinguish these populations, although expression of Helios and neuropilin and methylation status of the T reg cell-specific demethylation region (TSDR) have been proposed [4] [5] [6] [7] [8] . Conventional T (T conv ) cells express their own master transcription factors; these include T-BET + type 1 helper T (T H 1) cells, GATA3
+ T H 2 cells and RORγ t + T H 17 cells 9 . These transcription factors are considered to antagonize T reg cell development: in mice, induction of high T-bet expression in T reg cells within inflamed bowel drives T reg cells into a pro-inflammatory phenotype reminiscent of T H 1 cells 10 . This view has been challenged by specific deletions of these factors specifically within Foxp3 + cells of mice [11] [12] [13] [14] . For example, T-bet expression within Foxp3
+ T reg cells is required for trafficking to and suppression of T H 1 cell-mediated inflammation 13 , and Gata3 is required for full T reg cell function in the gut 14 . These findings support a 'compartmentalized' view of T reg cells, suggesting multiple subpopulations defined by expression of transcription factors associated with T conv cell lineages and by specialized functions. Indeed, the transcription factor circuitry of T reg cells is complex, with significant interplay between Foxp3 and other lineage-associated transcription factors 15 . In humans, heterogeneous populations of T reg cells have been reported, although typically defined by surface markers (for example, CD39, HLA-DR and CD45RA 1 ) rather than transcription factors. Whether these subpopulations have the ability to suppress specific parts of the human immune system has yet to be fully elucidated. Conventional methods for delineating T reg cell subsets are limited by numbers of markers that can be concurrently used and by biased approaches to data analysis (gating of T reg cell subsets) 16 . This has led to conflicting results, with memory T reg cells being reported as both non-suppressive 17 and highly suppressive 18 . By contrast, unbiased multidimensional analysis can delineate the most suppressive T reg cell subpopulations, identify new ones and exclude those less likely to be regulatory 16 .
Human retinoic acid-regulated CD161

+
regulatory T cells support wound repair in intestinal mucosa
Inflammatory bowel disease (IBD) represents a complex collection of disorders in which aberrant mucosal immune system activation, epithelial barrier dysfunction and microbial dysbiosis contribute to chronic inflammation and unregulated local T H 1 cell and T H 17 cell responses 19 . Bowel mucosa is a key site for the peripheral induction of T reg cells from naïve CD4
+ precursors via instruction from environmental factors, such as transforming growth factor-β (TGF-β ), IL-2 and all-trans retinoic acid (ATRA) 20 . T reg cells mediate dominant tolerance in gut mucosa, preventing or ameliorating murine colitis after adoptive transfer 21 . Conversely, FOXP3 mutations or disruption of other key T reg cell molecules (for example, CTLA-4, IL-10R and TGF-β ) cause enteropathy in humans and mice 2 , demonstrating their key role in preventing gut inflammation. Lamina propria T reg cells increase in number in IBD, but it is unclear why they do not control local inflammation and what function(s) they perform in these diseases 22 . T reg cells can express RORγ t together with IL-17A and, in humans, these factors are restricted to a T reg cell subset that expresses CD161 23 . CD161 is a C-type lectin-like receptor expressed on human natural killer (NK) cells 24 and various T lymphocyte subsets 25 . CD161
+ T conv cells are memory cells that act as T H 17 cell precursors 26 . The CD161 cognate ligand is lectin-like transcript 1 (LLT1) 27 . Single-nucleotide polymorphisms associate with IBD in genome-wide association studies 28 , suggesting that the CD161-LLT1 interaction is physiologically important.
Here we delineate the biological repertoire of CD161 + T reg cells, their role in the immune system and their mechanisms of action. Our data show that CD161
+ T reg cells are a highly suppressive, distinct subset of induced T reg cells that accelerate the wound healing of colorectal epithelium via the production of soluble factors in a BACH2-dependent manner.
Results
CD161-expressing T reg cells are a discrete population with a distinct TCRBV repertoire.
We used an unbiased multidimensional analysis pipeline via cytometry by time-of-flight (CyTOF) to identify and study biologically important human T reg cell subpopulations. Visualized stochastic neighbor embedding (viSNE) was used to create a map of CD4 + T cells from blood and arrange cells along t-distributed stochastic neighbor embedding (t-SNE) axes based on per-cell phenotypic similarity 16, 29 (Fig. 1a,b) . T reg cells, identified by high expression of CD25 and FOXP3 and low expression of CD127, clustered together and could be resolved into naïve and memory populations (Fig. 1a,b) . Likewise, T conv cells, identifiable by low expression of CD25 and FOXP3 and high expression of CD127, clustered together and distinctly from T reg cells (Fig. 1a,b) . In this unsupervised analysis, the C-type lec- (Fig. 1a,b ). To identify distinct T cell clusters, we performed a spanning-tree progression analysis of densitynormalized events (SPADE) 30 based on t-SNE values. Differential expression of markers within each identified SPADE node was used to further cluster T cells. This analysis resolved CD4 + T cells into 50 subpopulations, grouped into four main populations: naïve T reg cells, memory T reg cells, naïve T conv cells, and memory T conv cells, characterized by different expression profiles ( Fig. 1c and Supplementary Fig. 1a ). CD161-expressing cells represented a distinct subpopulation of memory T reg cells and several subpopulations of memory T conv cells, which were all distinct from T reg cells (Fig. 1c) . To further distinguish T reg cells from T conv cells, we performed similar analysis of transcriptomes by single-cell RNA sequencing (RNAseq) using CD4 +
CD25
+ cells as input ( Supplementary Fig. 1b-e ). This pipeline resolved cells into nine clusters, of which two were T reg cells (clusters 0 and 3), five were T conv cells (clusters 1, 2, 4, 5 and 6) and two were probably T reg cells, although they were too small in number to subcategorize (clusters 7 and 8) ( Supplementary  Fig. 1b-e) . The two T reg cell clusters (clusters 0 and 3) were clearly separate from the T conv cell clusters, and one of them (cluster 3) expressed KLRB1, the gene encoding CD161 ( Supplementary  Fig. 1b- Fig. 1e ) and was similar to heatmaps constructed from protein expression by CyTOF (Supplementary Fig. 1f) . A similar unsupervised pipeline applied to CD4 + T cells flow-stained with just five markers, CD4, CD25, CD127, CD45RA and CD161, produced viSNE and SPADE plots similar to those of CyTOF ( Supplementary Fig. 1g,h ) and could be used to flow sort peripheral blood T reg cell subpopulations for further analysis ( Supplementary  Fig. 2a,b) Among the TCRBV families, the three highest contributors to the total TCR repertoire (BV05, BV06 and BV07) and one of the lower contributors (BV19) were chosen to represent variability of the cellular repertoire by spectratyping. CD161
+ T reg cells were polyclonal, had normally distributed CDR3 (complementarity-determining region 3) length in the different TCRVB families (Fig. 1d) and had a contribution to the overall TCR repertoire similar to that of other T cell subsets ( Supplementary Fig. 2d ). We asked whether the TCR repertoire of CD161 + T reg cells overlapped that of either the T reg cell or T conv cell populations and found limited clonality shared by the different subsets; in particular, CD161
+ T reg cells shared only 4.5% and 4.8% of TCR sequences with memory T reg cells and CD161 + T conv cells, respectively ( Supplementary Fig. 2e ). We calculated the Morisita-Horn similarity index to measure TCR composition overlap between the different T cell populations 32 ; this index ranges between 0 (minimal similarity) and 1 (maximal similarity). Limited TCR repertoire overlap existed between any of the populations other than between CD161
+ T conv cells and T conv cells (a value of 0.413) (Fig. 1e) . Hierarchical clustering, based on the Morisita-Horn similarity index, indicated two subdivisions, separating the two T conv cell populations from all three T reg cell populations; moreover, CD161 + T reg cells clustered with memory T reg cells within the T reg cell main branch (Fig. 1f) . These data indicate that CD161
+ T reg cells have TCR repertoires distinct from those of other T reg cells and do not represent a clonal expansion from a T conv cell population.
CD161
+ T reg cells share features with both CD161 + T conv cells and classical T reg cells. To identify similarities and differences between the three subpopulations, we compared their transcriptomes using microarray and gene-set enrichment analysis (GSEA) ( Supplementary Fig. 3a-d ). Despite CD161 + T reg cells' being a subpopulation of memory T reg cells, there were 549 genes differentially expressed in a comparison of CD161 + T reg cells with memory T reg cells (Fig. 2a, Supplementary Fig. 3b-d (Fig. 2b,c and Supplementary  Fig. 3e,f) . These data suggested that in addition to core T reg cell genes, they express a range of other transcripts related to CD161 induction or signaling.
All three T reg cell populations had similar FOXP3 protein expression (Fig. 2d) . We measured the methylation status of the FOXP3 TSDR and two other key T reg cell-associated genes, IL2RA and CTLA4, in the three T reg cell populations and, for comparison, T conv cells (Supplementary Fig. 3g ). Methylation at IL2RA and CTLA4 + T cells. Node size represents cell number, and color indicates CD161 median intensity. Grouped together are naïve (circled in orange), memory (circled in yellow) and CD161 + (circled in purple) T reg cells, as well as populations of naïve (circled in black), memory (circled in blue) and CD161 + (circled in red) T conv cells. Panels a-c show representative data from n = 3 experiments. d, Representative spectratype histograms from n = 3 experiments showing percentage of unique CDR3 sequences (templates) versus CDR3 length for the three highest (BV05, BV06 and BV07) and one of the lowest (BV19) TCRBV families contributing to the overall TCR repertoire in the indicated populations. e, Average Morisita-Horn similarity index of total TCRBV repertoire between the T cell populations (cumulative data from n = 3 experiments). f, Dendrogram showing linkage distance based on the Morisita-Horn similarity index.
loci was similar among the three T reg cell populations but was distinct from that of the more highly methylated T conv cells ( Fig. 2e and Supplementary Fig. 3h ). At the FOXP3 TSDR, we noted that CD161 + T reg cells have methylation intermediate (55%) between that of naïve (25%) or memory (28%) T reg cells and T conv cells (88%) (Fig. 2e and Supplementary Fig. 3h) . CD161
+ T reg cells were enriched in ATRAregulated genes compared with memory T reg cells (Fig. 3a) by GSEA, including genes encoding two gut-homing markers, CCR9 and ITGA4, which are classical ATRA-regulated genes ( Fig. 3a and Supplementary Fig. 4a ); CCR9 was confirmed at the protein level by flow cytometry (Supplementary Fig. 4b ). Activation of freshly isolated T reg cells with ATRA induced the expression of both CCR9 and CD161 (Fig. 3b) . Since T reg cells interact with dendritic cells (DCs) in the gut, we determined whether mature DCs generate ATRA via a functional assay for the key enzyme aldehyde dehydrogenase (ALDH). Lipopolysaccharide-matured DCs expressed substantial ALDH enzyme (Fig. 3c ) together with LLT1, the natural ligand for CD161 (data not shown) 27 . In the absence of DCs, T reg cells lost CD161 expression; whereas co-culture of freshly isolated T reg cells with DCs induced CD161. Addition of BMS493, a pan-retinoic acid receptor (RAR) inverse agonist, blocked CD161 expression in a dose-dependent manner ( Fig. 3d and Supplementary Fig. 4c ). To see whether ATRA directly regulates CD161, we scanned the KLRB1, which encodes CD161, and CCR9 loci (as control) for retinoic Fig. 4d ). One potential RARA site in KLRB1 and multiple sites in CCR9 were identified ( Supplementary Fig. 4e ). By RARA chromatin immunoprecipitation (ChIP)-quantitative PCR (qPCR), we found that ATRA enhanced RARA's binding at both loci in T cells, evident as a significant increment in percentage of input for both KLRB1 and CCR9 target sequences after culture with ATRA, compared with that of untreated cells (Fig. 3e) . Collectively, these data indicate that ATRA can induce CD161 expression on T reg cells.
+ T reg cells are a highly suppressive T reg cell population. We next tested the ability of CD161 + T reg cells to suppress T conv cell proliferation ex vivo by measuring the ratio of T reg cells to T conv cells required to suppress proliferation by 50% (half-maximal inhibitory concentration (IC 50 )) for each population 36 (Fig. 4a,b and Supplementary Fig. 5a ,b). CD161 + T reg cells had a lower mean IC 50 than that of memory T reg cells, whereas naïve T reg cells did not reach 50% suppression ex vivo (and therefore IC 50 could not be calculated) ( Fig. 4b and Supplementary Fig. 5b ). CD161
+ T reg cells remained stably regulatory even after in vitro proliferation for 2 weeks ( Supplementary Fig. 5c ). Separation of T reg cells from target cells by a transwell abolished the majority of the suppressive function of CD161 + T reg cells ( Supplementary Fig. 5d ), suggesting contact-dependent effects, and consistent with other T reg cell populations 37 . The presence of anti-CD161, anti-PD-L1, anti-TGFβ RII or anti-IL-10R caused no significant impairment of CD161 + T reg cells' suppressive function, indicating that suppressive function is likely not due to a single factor ( Supplementary Fig. 5e ). Furthermore, suppression assays under T H 1-and T H 17-skewing conditions did not impair regulatory function in CD161 + T reg cells ( Supplementary  Fig. 3f ). CD161 is found on NK cells 24 , and cytotoxicity is a suppressive mechanism of some T reg cells 38 . However, we found neither perforin nor granzyme (A or B) in any of the T reg cell populations ( Supplementary Fig. 5g ) and found no evidence of T conv cell cytolysis after co-culture with CD161
+ T reg cells (data not shown). The mouse CD161 ortholog is not expressed on T cells (Supplementary Table 2 ). To confirm suppressive ability of CD161 + T reg cells in vivo, we used a humanized mouse model of severe xenograft-versus-host disease (GvHD) in NOD-SCID-Il2rg −/− (NSG) mice by injecting CD25-depleted human peripheral blood mononuclear cells (PBMCs) with or without in vitro-expanded memory or CD161
+ T reg cells. Mice that received either memory T reg cells or CD161
+ T reg cells were protected from xeno-GvHD, surviving significantly longer than mice injected with PBMCs alone, and had a significant reduction in clinical disease scores (Fig. 4c) . Thus, CD161
+ T reg cells had suppressive activity comparable to that of traditional T reg cells in vivo. These data indicate that CD161
+ T reg cells are highly regulatory both in vitro and in vivo.
CD161 ligation stimulates cytokine production in CD161
+ T reg cells. We next investigated the specific effects of TCR triggering by examining transcriptomes of T reg cells stimulated with anti-CD3 + CD28 for 4 hs. Approximately 1,500 transcripts showed changes from baseline in CD161 + T reg cells ( Fig. 5a and Supplementary Fig. 6a,b) . Although a core set of transcripts, including KLRB1, RORC and CCR9, differed between CD161
+ T reg cells )   IL10   CD40LG  CD38  CCR6  KLRB1  CCR2  MAF  B3GALT2  HRH4  AUTS2  LMO4  PTPN13  PERP  CCR9  AIM2  CCL20  SLAMF1  RORC  POU2AF1  SLC7A8  ACSS2  HCRP1  CCDC141  NBEAL1  TTN  FCRL3  IKZF2  GCNT4  SELP  VNN2  RTKN2  ST8SIA6  RIMKLBP1   IL17A  IL17F  IL21  IL5 + T reg cells stimulated for 3 d with either anti-CD3 + CD28 + IgG2-or anti-CD3 + CD28 + CD161-coated magnetic beads (cumulative data from n = 4 experiments). Bar charts shown mean + s.e.m. throughout. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 by one-way (d,e) and two-way ANOVA (f). NS, not significant. and memory T reg cells, both before and after these cells were activated, there was little overlap (Fig. 5b,c) . Of note, a number of cytokine-encoding genes, including IL10, IL17A, IL17F and IL21 (Fig. 5c ), were enriched in CD161 + T reg cells ( Supplementary  Fig. 6b ). We confirmed preferential accumulation of IL-10, IL-17A, IL-22 and IL-4, but not of interferon-γ (IFN-γ ), in 3-day supernatants of α CD3 + CD28-activated CD161 + T reg cells (Fig. 5d) Fig. 6c,d ) and testing their respective suppressive functions. IL-17 + CD161 + T reg cells remained highly suppressive despite producing IL-17 (Fig. 5e) .
CD161 does not have classical immunoreceptor tyrosine-based activation or immunoreceptor tyrosine-based inhibitory domains, but its ligation can have both activating functions and inhibitory functions, depending on the cell type 25, 39 . To assess the function of CD161 in T reg cells, we stimulated cells with anti-CD3 + anti-CD28 magnetic beads additionally coated with anti-CD161 or an immunoglobulin-γ 2 (IgG2) isotype. After 3 d of culture, CD161 cross-linking significantly enhanced cytokine production from CD161 + T reg cells (Fig. 5f ), indicating that CD161 acts as a co-stimulatory molecule in CD161
+ T reg cells. Thus, CD161 + T reg cells are a cytokine-producing population of T reg cells, CD161 co-ligation is co-stimulatory to this process, and IL-17 production is compatible with suppressive function.
Genome-wide chromatin landscapes define regulatory circuitry in CD161
+ T reg cells. We next examined global chromatin landscapes of naïve, memory and CD161
+ T reg cells directly ex vivo using high-throughput assay for transposase-accessible chromatin using sequencing (ATAC-seq), hypothesizing that these dictate differences in biological function. Open chromatin regions (OCRs) surrounding the signature T reg cell-associated genes, notably FOXP3, CTLA4 and IL2RA, were not significantly different among the three populations ( Supplementary Fig. 7a ). We focused on ~1,300 OCRs that have consistent patterns among all three biological replicates but differ among the three T reg cell populations. These regions were in three clusters: those specific to naïve T reg cells (25% of total), those specific to CD161 + T reg cells (39% of the total), and those shared by CD161 + T reg cells and memory T reg cells (37% of the total) (Fig. 6a,b Table 3 ). The genomic distributions of OCRs were similar in the three clusters, with the majority within intronic and intergenic regions ( Supplementary Fig. 7b ).
To determine potential transcription factors targeting distinct T reg cell regulomes, we searched for enrichment of known motifs above background within OCR clusters using HOMER software ( Fig. 6c and Supplementary Fig. 7c ). CD161
+ -specific OCRs were enriched for motifs of RORγ t, RUNX, AP-1 family (for example BATF, FOSL2), and cap'n' collar family members that include BACH2 ( Fig. 6c and Supplementary Fig. 7c ). We performed GSEA for genes regulated by BACH2, RORγ t, BATF, FOSL2 and RUNX1. CD161
+ T reg cells were enriched for BACH2, RORγ t, FOSL2 and RUNX1 regulated genes, compared with memory T reg cells (Fig. 6d) . Approximately 40% of the 549 genes expressed differentially in CD161
+ T reg cells relative to their expression in memory T reg cells could be attributed to regulation by the transcription factors encoded by Bach2, Runx1, Rorc, Fosl2 and Batf in mice using knockout models 3, 40, 41 , with BACH2 being responsible for the majority of the transcriptional differences (Fig. 6e) . Expression of BACH2 itself was significantly reduced and that of RORC was significantly elevated in freshly isolated CD161
+ T reg cells compared with that of other T reg cell populations ( Supplementary Fig. 7d ), suggesting that altered expression of these transcription factors could explain some of the transcriptional differences seen in their targets. CD4
+ T cells from a patient heterozygous for a BACH2 L24P mutation that renders her BACH2 haploinsufficient 42 showed over-representation of the CD161 + T reg cell subset relative to that of controls (Fig. 6f) , confirming that low BACH2 expression is important for the development and/or persistence of these cells. An integrated network was constructed based on these effects to illustrate the transcriptional circuitry ( Supplementary Fig. 7e ). Genes controlled solely by BACH2 regulated cell division, whereas genes co-regulated by BACH2 and the other transcription factors in this model were especially involved in wound healing (Fig. 6g) . These data point to distinct regulomes in CD161
+ T reg cells imparting novel functions, including wound healing.
CD161
+ T reg cells are enriched in IBD, enhance wound healing and associate with reduced inflammation. We confirmed by GSEA that activated CD161
+ T reg cells were enriched for genes encoding wound-healing molecules (for example, PDGFA and CFS2), including soluble mediators (for example, IL17A and IL22), compared with other T reg cell populations ( Supplementary Fig. 8a,b ). Since CD161 + T reg cells expressed CCR9 and ITGA4 ( Fig. 3a and Supplementary  Fig. 4a,b) , we determined whether they were enriched in the bowel during inflammation by comparing T reg cell populations in matched peripheral blood to colonic biopsies of healthy individuals and those with Crohn's disease (CD). There was mild enrichment of naïve and memory T reg cells in colonic mucosa compared with blood. By contrast, there was a significant enrichment of CD161 + T reg cells in healthy colons, which was even more pronounced in patients with CD (Fig. 7a) . LLT1, the CD161 ligand, is expressed in inflamed areas 27 , which we speculated would drive cytokine expression in CD161
+ T reg cells. We therefore tested the effect of CD161 + T reg cell supernatants on wound healing using a human epithelial colorectal adenocarcinoma cell line (Caco-2 cells) to approximate bowel epithelium. Supernatants from activated CD161 + T reg cells increased and accelerated closure of the wound by almost twofold compared with supernatants from memory T reg cells or medium alone (Fig. 7b,c, Supplementary Fig. 8c and Supplementary Videos  1-3) . Neutralization of IL-17 alone, IL17 together with IL-22, IL-4 or IL-10 impeded the wound-healing capacity of supernatants of activated CD161
+ T reg cells, implicating these cytokines as mediators of wound healing (Fig. 7d) . Over-expression of BACH2 by lentiviral delivery in CD161 + T reg cells significantly inhibited the production of IL-17 and IL-4, with a similar but not significant trend for IL-22 and IL-10 ( Fig. 7e and Supplementary Fig. 8d ), supporting the notion that the wound-healing program of CD161 + T reg cells is dependent on reduced expression of the repressive BACH2 transcription factor in these cells.
The suppressive function of CD161 + T reg cells and their ability to accelerate wound healing suggested that they might be beneficial in IBD. To explore this possibility, we examined RNA-seq from a large dataset of patients with CD (Gene Expression Omnibus accession code GSE57945) for expression of KLRB1, which encodes CD161. KLRB1 correlated negatively with 15 genes previously shown to be upregulated in inflamed CD mucosa, relative to its expression in uninflamed CD mucosa 43 (Fig. 7f ). Of these, CXCL1, a clinical biomarker of CD, was significantly more highly expressed in inflamed CD mucosa than in uninflamed CD mucosa, while KLRB1 expression was significantly higher in uninflamed CD mucosa (Fig. 7g) Fig. 7e ) (left) and corresponding function for those DEGs (right). GO, gene ontology. Data for a-e and g are from n = 3 independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 by Fisher exact test. + T reg cells with blocking antibodies to stated cytokines or isotype-matched control antibody (cumulative data from n = 3 experiments). e, Concentration (pg ml 
) of stated cytokines in supernatants of CD161
+ T reg cells transduced, or not, with lentivirus encoding BACH2 or control virus (cumulative data from n = 6 experiments). f, Correlation matrix of indicated transcripts in bowel specimens of active CD (n = 171). g, Violin plots showing distribution of CXCL1 (left) and KLRB1 (right) expression in inflamed (n = 157) and uninflamed CD or non-IBD tissue biopsies (n = 56). h, ROC curves showing performance of CXCL1, IL7R, KLRB1 and KLRB1/IL7R ratio to discriminate inflamed tissue (n = 157) versus uninflamed CD or non-IBD tissue (n = 56). AUC analyses and their P values indicated. i,j, KLRB1/IL7R ratio in transcriptomes of inflamed and uninflamed sites of CD (i) and AUC + 95% confidence interval (CI) of KLRB1/IL7R ROC curves to distinguish the two (j) from two additional, independent, datasets. Numbers of biologically independent samples (n) in i is indicated. Median, upper and lower quantile, range and outliers are presented in i. In j, areas of circles indicate sample size. Source data for f-h: GSE57945; i,j: GSE20881 and ref. 75 . Bars show mean + s.e.m. throughout; *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 by one-way (d,e) and two- way ANOVA (a,c), t-test (g,i) and AUC analysis (h,j).
receiver operating characteristic (ROC) curve for KLRB1/IL7R was highly significant (area under the ROC curve (AUC) = 0.77; P value < 0.0001) and performed well compared with CXCL1, slightly better than KLRB1 and substantially better than IL7R alone (Fig. 7h) when predicting inflamed versus uninflamed mucosa. We used two additional transcriptome datasets from CD mucosa as validation datasets. In all cases, the KLRB1/IL7R predictor was higher in uninflamed CD mucosa (Fig. 7i) and distinguished inflamed mucosa from uninflamed mucosa (AUC range, 0.63 to 0.79; Fig. 7j ), suggesting that tissue infiltration with CD161
+ T reg cells is associated with lower inflammation in CD. These data suggest that CD161 + T reg cells are enriched in colonic mucosa, particularly in IBD, where they suppress inflammation and produce soluble factors that accelerate epithelial barrier healing, having a beneficial effect on outcomes.
Discussion
Understanding biologically important and clinically relevant T reg cell populations is key to elucidating disease mechanisms and tailoring immunotherapy. We delineated CD161
+ T reg cells in humans, showing them to be a distinct, highly suppressive, bona fide retinoic acid-dependent subpopulation enriched in lamina propria and associating with regions that have lower inflammation in CD. We show that they can enhance wound healing through soluble mediators and that transcriptional control involves a transcription factor network in which BACH2, RORγ t, RUNX1, FOSL2 and BATF all play a role. We show phenotypic distinction of CD161 + T regs from T conv cells, including a unique TCR repertoire that is different from that of T conv cells and T H 17 cells. Thus, it is highly unlikely that they are contaminating T conv cells. We conclude that they are a distinct subpopulation of T reg cells with stable regulatory function. CD161 + T reg cells are either induced to develop or specialize in the periphery, consistent with absence of CD161 + T reg cells in cord blood 23 and thymus (our unpublished observations) and relatively small circulating numbers. Murine RORγ t + T reg cells can either develop in the colon from naïve CD4 + T cells by local microbiota to suppress intestinal inflammation, although these cells do not produce IL-17 44 , or from thymic T reg cell émigrés following immunization 45 . We identified that human CD161 + T reg cells have a retinoic acid-regulated gene signature and that retinoic acid directly regulates KLRB1, the gene encoding CD161. Since bowel is rich in retinoic acid, an area for T reg cell generation, and since CD161 + T reg cells expressed CCR9, a gut-homing chemokine receptor, it was unsurprising that the lamina propria was enriched in CD161 + T reg cells, particularly in IBD. This is consistent with inflamed bowel as an enrichment site for FOXP3
+ IL-17 + T cells 46 . Thus, CD161 + T reg cells appear to be either induced or migrate to lamina propria.
Some OCRs were broadly accessible in all three T reg cell populations we studied, including T reg cell lineage-associated loci, for example FOXP3, CTLA4 and IL2RA, consistent with similar protein expression in all the subsets. The regulomes of CD161 + T reg cells differed from memory T reg cells by only ~500 OCRs, congruous with relatively small transcriptional differences between them. The transcription factor circuitry explaining these differences was dominated by BACH2, which was itself expressed at lower level in CD161
+ T reg cells than in memory T reg cells. The importance of low BACH2 expression for development and/or persistence of these T reg cells was demonstrated by excess of CD161 + T reg cells in a patient with genetic BACH2 haploinsufficiency. As BACH2 restricts T cell effector programs 3 , it is unsurprising that de-repression by BACH2 imparts functional properties to T reg cells resembling T conv cells, notably cytokine production, without loss of suppressive phenotype. This is supported by significantly diminished cytokine production with BACH2 over-expression in these T reg cells. Notably, CCR9 is a classic BACH2-repressed gene 3 Although the association between CD161 and T H 17 cell programs in T conv cells is known, it was unexpected that transcriptomes of activated CD161
+ T reg cells encode complex cytokine cocktails. Since IL-17 can be pro-inflammatory and is associated with autoimmunity, it was possible that IL-17 expression could have denoted a pro-inflammatory function. Indeed, in mice, RORγ t + T reg cells can promote autoimmunity and cancer 47, 48 . Our data, however, indicate that actively IL-17-producing T reg cells remain highly suppressive and we found no evidence that CD161 + T reg cells are a transitional or unstable population, consistent with mouse models where adoptive transfer of IL-17 
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+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503-4515 (2011 ) and ionomycin (1 mM, both from Sigma) with the addition of Brefeldin A (3 μ g ml
; eBioscience) before staining. Additional staining of T reg cells were further stained for invariant chains TCRVα 24-Jα 18 (6B11) and TCR Vα 7.2 (3C10, both from Biolegend), perforin (dG9, eBioscience), granzyme A (GB11, Biolegend) and granzyme B (CB9, Biolegend) using appropriate flurochrome-conjugated antibodies. Flow cytometry data were acquired on an LSR Fortessa (BD) and subsequently analyzed using FlowJo version 10.1 (TreeStar).
Mass cytometry (CyTOF).
For mass cytometry, 2 × 10 6 CD4 + CD127 lo cells were isolated using RosetteSep Human CD4 + CD127 low T Cell Enrichment Cocktail (STEMCELL Technologies) before extracellular and intracellular staining with metal conjugated antibodies. For full list of both antibody panels refer to Supplementary Table 4 . A CyTOF-2 mass cytometer (Fluidigm) was used for data acquisition and beads (Ce140) were used for normalization 29 . A total of 320,000 cells were proportionally sampled from all individuals to perform automated clustering. Data were initially processed and analyzed using Cytobank 29 ; CD4 sample 'clean-up' was performed by gating on intact (191Ir
+ (Sm154) and CD4 + (Nd145) T cells. Mass cytometry complex data were analyzed using viSNE, in combination with SPADE, to identify distinct subpopulations 30,55 using the following parameters: CCR6 (141Pr), CD45RA (143Nd), CCR4 (149Sm), CD161 (150Nd), CD103 (152Sm), CD62L (153Eu) Helios (156Gd), CCR7 (159Tb), Tbet (160Gd), CD95 (161Dy), CXCR3 (163Dy), CD45RO (164Dy), GATA3 (167Er), CCR9 (168Er), CD25 (169Tm), Foxp3 (171Yb), CXCR4 (173Yb), HLA-DR (174Yb), CD127 (176Yb). viSNE and SPADE plots were generated using Cytobank. Where indicated in the figure legend, figures were overlaid for demonstration purpose.
T cell culture. Unless indicated otherwise, cells were cultured in X-Vivo 15 with Gentamycin and PR (Lonza) supplemented with penicillin-streptomycin glutamine (PSG, Thermo Fisher) and 5% human AB serum (Biosera), henceforth shortened to X-Vivo 5% HS; cells were then seeded at 10 6 cell ml
. For the evaluation of the effect of ATRA on CD161 expression, 250,000 total T reg cells were isolated and stimulated for 48 h with 1:1 ratio of α CD3/CD28 Dynabeads in X-Vivo 5% HS supplemented with 100 IU ml −1 of IL-2 (Proleukin, Novartis), in the presence of 0, 0.02, 0.2 or 2.0 μ M ATRA (Sigma-Aldrich); cells were then stained for CD4, CD161 and CCR9 and the effects of ATRA on expression of CD161 (stained with antibody clone DX12 from BD) and CCR9 (stained with antibody clone L053E8 from Biolegend) was evaluated by flow cytometry.
For T reg cell expansion to facilitate in vivo models, sorted memory and CD161 + T reg cells were cultured in X-Vivo 5% HS supplemented with 1,000 IU ml −1 IL-2 and stimulated with anti-CD3 + CD28 Dynabeads at a 1:1 ratio for 2 or 3 rounds of expansion of 10-14 d each. Beads were removed by magnetic adherence following each round of stimulation and fresh anti-CD3 + CD28 Dynabeads (1:1 ratio) added. After the last round of expansion, beads were removed and the cells were rested for 2 d before injection. Cell viability was close to 100% before each in vivo experiment.
To evaluate the effects of CD161 cross-linking on cytokine production, CD161
+ T reg cells were cultured for 3 d in X-Vivo 5% HS, supplemented with 100 IU ml −1 IL-2 and stimulated 1:1 with microbeads from the T cell activation/ expansion kit (Miltenyi Biotec) loaded with anti-CD3 and anti-CD28 following the manufacturer's instructions with the addition of anti-CD161 (191B8, MiItenyi) or IgG2a (eBM2a eBioscience).
T reg cell suppression assay. Cryopreserved T conv cells (CD4 + CD25 − ) were used as target cells throughout. These were isolated by negative selection of CD4 + T cells followed by positive selection of CD25 + T cells using miniMACS CD4 + CD25 + T Regulatory Cell Isolation Kit (Miltenyi Biotec) according to the manufacturers' instructions. T conv cells were obtained from the CD25 − negative fraction. Cryopreserved T conv were thawed and labeled with either 2.5 μ M carboxyfluorescein diacetate, sucinnimydil ester (CFSE) (Molecular Probes) or 1 μ M CellTrace Violet (Molecular Probes) according to the manufacturers' instructions. T conv cell viability was routinely greater than 95% before suppression assay. Suppression assays were conducted in X-Vivo 5% HS and U-bottom 96-well plates incubated at 37 °C, 5% CO 2 for 5 d, at constant T conv cell number (10 5 cells) and T reg cell:T conv cell ratio of 1:1 or 1:2, as indicated. Where indicated, T reg cell numbers were titrated to result in a T reg cell: T conv cell ratio of 1:1 to 1:32 ratio. Cells were stimulated with α CD3/ CD28 Dynabeads (bead:cell ratio of 1:40) and CFSE/CellTrace Violet dilution was assessed by flow cytometry on day 5. Percentage of suppression and IC 50 were calculated as previously described 36 . Where indicated, T reg cell suppression was also evaluated in the presence of either 10 μ g ml −1 anti-CD161 (BD Pharmingen), 10 μ g ml −1 anti-PDL-1 (eBioscience), 10 μ g ml −1 anti-IL-10R (Sigma), 1 μ g ml
α TGFBRII (R&D) or in the presence of T H 1 (40 ng ml −1 IL-12 (Biolegend) and 5μ g ml −1 anti-IL-4 (R&D)) or T H 17 (40 ng ml −1 IL-1β (R&D) and IL-6, 10 ng ml
TGF-β 1 (both from Biolegend), 50 ng ml −1 IL-23 and 5μ g ml −1 anti-IL-4 and antiIFNg, all from R&D) skewing conditions.
For the transwell suppression assay, the HTS Transwell-96 Permeable Support with a 0.4 μ m pore polycarbonate membrane system (Corning) was used. Suppression was tested at a 1:1 T reg cells:T conv ratio and T conv were seeded in the lower compartment of the transwell plate, while T reg cells were seeded on to the upper compartment. Cells in both the upper and lower chambers were stimulated with anti-CD3 + CD28 Dynabeads (bead:cell ratio of 1:40). As reference of standard suppression, T reg cells and T conv were also co-seeded in the lower compartment.
Gene expression analysis.
For gene expression analysis, 200,000 naïve, memory and CD161
+ T reg cells were either sorted from fresh blood directly into Trizol LS (Ambion) for baseline genetic profile or cells were polyclonally activated postsorting for 4 h with Dynabeads Human T-Activator CD3/CD28 (ratio 1:1) and then lyzed in Trizol LS. RNA was isolated using RNeasy mini kit (QIAGEN) and Ovation PicoSL WTA System V2 (NuGEN Technologies) was used for reverse transcription and complementary DNA amplification steps. Fragmentation and labeling was performed using the Encore Biotin Module (NuGEN Technologies); all kits were employed following the manufacturer's instructions. Samples were run on GeneChip Human Gene 1.0 ST Array (Affymetrix). Data analysis was performed using Partek Genomic SuiteTM (Partek Incorporated). Thresholds for significance were set at 1.5-fold difference at P < 0.05 for freshly isolated cells and 2-fold difference at P < 0.05 for in vitro-activated cells.
GSEA was performed using GSEA version 2. 3 (GSE45975), all at a significance threshold of 1.5-fold change and P < 0.05. Mouse gene symbols were converted to human homologs using the BioMart data-mining tool in ensemble (http://www.ensembl. org/biomart/martview). General wound-healing-associated genes were curated from published gene lists [57] [58] [59] , the 'resolve wound healing and fibrosis-related genes' dataset (http://www.resolve-whfg.appspot.com/list/Human/) and 'wound healing RT2 profiler PCR array' (Qiagen). Wound-healing-associated soluble mediators were defined as the online dataset for 'cytokines in wound healing (R&D Systems)' supplemented with cytokines and other soluble mediators from the general wound-healing-associated genes list.
Single-cell RNA-seq. The single-cell sequencing experiment was performed using the 10X Genomics' Chromium Single Cell 3′ gene expression V2 kit following the manufacturer's instruction. CD4
+ CD25 + T cells were freshly isolated from peripheral blood of three healthy donors. Cells were captured for each sample and libraries were sequenced on the Illumina Hiseq 3000 instrument. Raw reads from the three samples were combined and processed using 10x Genomics Cell Ranger v2.1 60 . The result was summarized into an expression matrix with the unique molecular identifier count for every cell and every gene. Genes expressed in < 3 genes and cells with < 200 genes detected or > 5% of the total unique molecular identifier count in mitochondrial genes were removed, resulting a final matrix comprising 2,636 cells and 15,357 genes. Dropouts were imputed using DrImpute 61 . We analyzed data using the R package Seurat 62 with default parameters if not specified. The top 15 principal components were used to compute the t-SNE plot. Resolution was set to 0.4 for clustering.
Methylation analysis. For CpG methylation analysis, 250,000 cells from each desired population were FACS sorted. CpG methylation analysis was determined by pyrosequencing of bisulphite-modified genomic DNA. Methylation analysis was conducted by EpigenDx, as previously described by ref. 63 . CpG methylation of FOXP3 TSDR (ADS783FS2), IL2RA (ADS4564FS) and CTLA4 (ADS3074FS2) loci shown in Supplementary Fig. 3g were evaluated. TCRBV sequencing. For TCRBV sequencing, 250,000 cells from each population were FACS sorted. Amplification and sequencing of TCRVB CDR3 was performed by Adaptive Biotechnologies using the immunoSEQ Platform 64, 65 . Analysis was performed using ImmunoSEQ analyser for spectratyping analysis and clone sharing among samples; to assess the overlap in TCR composition between populations, the Morisita-Horn similarity index 32 was calculated using R-Studio. Only productive (in frame and without included STOP codon) amino acidic (VJ) sequences were analyzed; the number of both common and specific sequences for each combination of populations was used to calculate the percentage of unique and shared sequences within the different populations.
DCs generation, mixed lymphocyte reaction and CD161 induction. From PBMCs, CD14
+ cells were isolated with CD14 microbeads (Miltenyi Biotec) and DCs generated by culturing for 5 d in X-Vivo 5% HS supplemented with 50 ng ml −1 GM-CSF (Peprotech) and 800 U ml −1 IL-4 (R&D). Maturation of the DCs was achieved by culturing for further 48 h with 50 ng ml −1 GM-CSF, 800 U ml −1 IL-4, 10 ng ml −1 of IL-1β , IL-6 (eBioscience), TNF-α (Biolegend), and 1μ g ml −1 of PGE2 (BioVision) and lipopolysaccharide (Sigma-Aldrich). To assess the capacity of the DCs to produce ATRA, the ALDEFLUOR kit (STEMCELL Technologies) was used to stain the cells for ALDH. Mixed lymphocyte reaction was performed by co-culturing DCs with total T reg cells for 5 d in the presence or absence of 1 μ M pan RAR inverse agonist (BMS493, Tocris Bioscience).
RARA ChIP-qPCR. JASPAR 66 was used to scan the sequences of both KLRB1 and CCR9 gene loci (± 5 kb from gene body) for predicted binding sites of ATRA. A total of 15 × 10 6 cells were cultured for 4 h in X-Vivo, not supplemented with human serum, in the presence or absence of 2 μ M of ATRA (Sigma-Aldrich). RARA ChIP-qPCR was then performed. Briefly, cells were fixed with 16% formaldehyde (ThermoFisher) and harvested in PBS containing protease inhibitors Aprotinin (MP Biochemicals), Leupeptin (Bachem), both at 1 μ g ml −1 and 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma). Frozen cell pellets were lyzed in SDS lysis buffer containing protease inhibitors and DNA sheared into lengths of 0.2-1.0 Kbp using a Branson sonicator (11% power amplitude). Samples were resuspended in 2 ml of ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100 (Sigma), 1.2 mM EDTA, 16.7 mM Tris HCl pH 8.1, 167 mM NaCl in dH 2 O) containing protease inhibitors; 100 μ l of samples were taken as input DNA and stored for downstream qPCR. To reduce non-specific binding, samples were precleared by incubation with salmon sperm DNA/protein A agarose-50% slurry (EMD Millipore). ChIPs were carried out using 10 μ l IP −1 of RARA polyclonal antibody (Diagenode C15310155) and salmon sperm DNA/protein A agarose-50% slurry. Slurry was then serially washed with low salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris HCl pH 8.1, 150 mM NaCl in dH 2 O) followed by high salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris HCl pH 8.1, 500 mM NaCl in dH 2 O), LiCl wash buffer (0.25 M LiCl (Sigma), 1% NP40 (ThermoFisher), 1% deoxycholate (ThermoFisher), 1 mM EDTA, 10 mM Tris HCl pH 8.1 in dH 2 O) and finally twice with TE buffer pH 8 before elution form the beads with elution buffer (1% SDS, 0.1 M NaHCO 3 ). Cross-linking was reversed with 5 M NaCl ml −1 and heating to 65 °C for 4 h; dissociated transcription factors and antibodies were digested by adding 0.5 M EDTA, 1 M Tris HCl (pH 6.5) and 20 mg ml −1 Proteinase K (ThermoFisher) followed by overnight incubation at 55 °C. DNA was precipitated with isopropanol and re-dissolved in dH 2 O before purification with MinElute PCR Purification Kit (QIAGEN). Primers for KLRB1 (forward: GTCCCCACCCACATACACTT; reverse: AGAACAAATGAGCCTCCCAGA) and CCR9 (forward: AGTTTCCCCTTATCCCAGCA; reverse: CAGCTACCCGATAACAACACG) were designed and used for quantification by qPCR. Percentage of input, normalizing the signal obtained from the ChIP against the input sample, was calculated.
Cytokine secretion measurement. To evaluate the cytokine production of the different populations of T reg cells after activation, 10 6 naïve, memory and CD161 + T reg cells were FACS sorted and activated for 3 d with 1:1 ratio of α CD3α CD28 Dynabeads and 100 U ml −1 of IL-2. Cytokine protein levels were measured in the supernatant by either T H 1/T H 2/T H 17 Cytometric Bead Array (CBA, BD) or LEGENDplex Human T helper Cytokine panel (Biolegend). To evaluate the effect of CD161 cross-linking on cytokine production, 100,000 cells were stimulated for 3 d with ratio 1:1 microbeads coated with either α CD3α CD28IgG2 or α CD 3α CD28α CD161 (T Cell Activation/Expansion Kit, Miltenyi Biotec, as previously described 25 ) and protein levels measured in the supernatant by LEGENDplex human T helper cytokine panel (Biolegend).
IL-17 capture assay. For the IL-17 capture assay, 10 6 CD161 + T reg cells were FACS sorted and then stimulated with PMA and Ionomycin for 5 h. IL-17-producing CD161 + T reg cells were then labeled using the IL-17 Secretion Assay Kit (Miltenyi Biotec) according to the manufacturer's instructions and then FACS sorted into IL-17 producing and non-producing cells. Cells were rested overnight and a standard suppression assay, including naïve and memory T reg cells as controls, performed. Simultaneous staining of surface and intracellular IL-17 was carried out on 10 6 CD4 + T cells by incubating cells for an extra 2 h in PMA/Io with supplementation of BD GolgiPlug, before washing and staining with surface IL-17 detection antibody (IL-17 Secretion Assay Kit, Miltenyi Biotec). Following extracellular staining and fixation/permeabilization, intracellular staining was then performed with a second α IL-17 antibody conjugated with a different fluorochrome. To validate the specificity of the double staining, staining with the antibody for intracellular IL-17 was also performed on cells without fixation/ permeabilization step, but after surface staining with IL-17 detection antibody; lack of double positive cells in the control sample demonstrated that the staining for intracellular IL-17 was specific.
In vitro wound-healing assay. The human intestinal cell line Caco-2 (clone HTB-37) was obtained from the European Collection of Cell Cultures, Health Protection Agency Culture Collection and grown in DMEM medium supplemented with 10% FBS (both from GIBCO) and 1% MEM non-essential amino acid solution (NEAA, Sigma-Aldrich). Cells were routinely tested for contamination by mycoplasma. A total of 250,000 Caco-2 cells were seeded into CytoSelect 24-well woundhealing assay plates (Cell Biolabs) and grown until confluence for 7 d. Sorted memory and CD161
+ T reg cells were stimulated for 3 d with 1:1 ratio of α CD3α CD28 Dynabeads and 100 U ml −1 of IL-2 in complete RPMI (GIBCO) with 10% v/v HS and supernatant collected. Supernatant from the cells was then diluted 1:4 with fresh DMEM 10% FBS 1% NEAA and added to the Caco-2 cells, after insert removal. As a negative control, RPMI 10% HS diluted with 1:4 with DMEM 10% FBS 1% NEAA was used. Time-lapse image capture was recorded using Biostation CT (Nikon) over a period of 120 h. Percentage of open wound was calculated using the 'wound healing' tool on NIS Elements Advanced Research Microscope Imaging Software (Nikon). For evaluation of the effect of cytokine blocking on wound healing, either IgG1a (5μ g ml
) together with IgG2b isotype (5 μ g ml −1 ), α IL-17 (5 μ g ml
), α IL-22 (5 μ g ml
), α IL-4 (5 μ g ml
), α IL-10R (10 μ g ml
), α IL-17 (5 μ g ml
) together with α IL-22 (5 μ g ml
) or α IL-10R (10 μ g ml ; all antibodies from R&D systems) were added to the wound-healing assay; image capture was recorded at start and at 120 h post culture.
Patient biopsies.
Six consecutive patients who attended the endoscopy department at King's College Hospital (London, UK) for a colonoscopy required in the context of their routine clinical care were consented for the study (REC 15/LO/1998). Three patients were recruited with an established diagnosis of CD, based on conventional clinical criteria, and three without any history of chronic IBD, but with gastrointestinal symptoms or anemia that required investigation; these latter patients were then considered as 'healthy individuals' with no diagnosis of CD. Peripheral blood was collected in EDTA tubes on the day of attendance to endoscopy and before colonoscopy. During colonoscopy, 2 mm biopsies were collected from inflamed sites in patients with CD or randomly for those without a diagnosis of IBD. Endoscopic findings of inflammation and/or normal macroscopic appearances were confirmed by histopathology.
PBMCs were isolated following standard isolation protocol and colonic lamina propria mononuclear cells (cLPMC) were isolated after digestion of the colonic tissue as previously described 67 . Both PBMCs and cLPMCs were then stained for CD45, CD3, CD8, CD4, CD25, CD127, CD45RA and CD161. Total CD4 + T cells were initially defined as CD45 + CD3 + CD8 − CD4 + and T reg cell subpopulations were then selected following standard gating strategy, as previously described. T reg cell populations were then compared in matched peripheral blood to colonic biopsy samples of healthy individuals and those with IBD.
Severe xeno-GvHD model. NOD/scid/IL-2Rγ −/− (NOD.cg-Prkdc scid Il2rg tm1Wjl / SzJ) mice (NSG; The Jackson Laboratory) were used between 8 and 10 weeks of age. Animals were bred and maintained in the Biological Services Unit of King's College London. All mice were kept under specific-pathogen-free conditions, and procedures were conducted in accordance with institutional guidelines (PPL70/7302) and the Home Office Animals Scientific Procedures Act (1986).
Sorted memory and CD161
+ T reg cells were cultured in X-Vivo 15 with gentamycin and PR (Lonza) supplemented with 5% human AB serum (HS, Biosera), 1,000 IU ml −1 of IL-2 (Proleukin, Novartis) and stimulated with Dynabeads Human T-Activator CD3/CD28 (GIBCO) at a 1:1 ratio for 2 or 3 rounds of expansion (10-14 d each). After the last round of expansion, beads were removed and the cells were rested for 2 d before injection into the mice. Human PBMCs (10 × 10 6 ) depleted of CD25 + cells were injected intravenously to induce xeno-GvHD with or without in vitro-expanded memory or CD161 + T reg cells (5 × 10 6 ) at a 2:1 PBMC:T reg cells ratio. Mice injected with PBS alone were used as negative control. Mice were monitored for symptoms of xeno-GvHD over time and the experiment was carried on until either a clinical score greater than 6 or a weight loss greater than 15% from the initial weight was reached. Clinical GvHD score was calculated by applying a modified scoring system (adapted from ref. 68 ): individual mice received a score of 0 to 2 for each criteria. Grade 0: < 5% weight loss, normal posture, activity, fur texture and skin integrity; grade 1: weight loss > 5% to < 10%, hunched posture only at rest, mild to moderately decreased activity, mild to moderate fur ruffling, scaling of paws/tail; grade 2: > 10% weight loss, severe hunching of posture impairing movement, severe ruffled fur/poor grooming, obvious areas of denuded skin. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
Data were analyzed using Excel, Prism, FlowJo, R and HOMER, as detailed under experimental procedures. Software used to hierarchically cluster SPADE data from CyTOF is now available here: https://github.com/kordastilab/cytoClustR For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Sample size
No statistical methods were used to predetermine sample sizes for animal experiments. From previous experience in our lab a sample size of n=5 mice per group is sufficient to detect a significant difference attributable to Treg function in xeno-GvHD Data exclusions No data have been excluded
Replication
All experiments have been replicated a minimum of three times except for in vivo work (n=2 experiments in order to minimize animal use and comply with the 3Rs of animal research use). Data included in the paper have been reliably reproduced.
Randomization Random allocation was used.
Blinding
No data blinding was required in these experiments.
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